HEALTH
<i> Times Staff and Wire Reports</i>
Genentech Reports Higher Earnings: The South San Francisco-based biotechnology company said increased demand for its drugs pushed up first-quarter profit 12%. Genentech Inc. earned $43.4 million, or 36 cents a share, for the three months ended March 31. It earned $38.9 million, or 33 cents a share, during the first quarter of 1994. Revenue rose 20%, to $239 million from $199 million.
